BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3547868)

  • 1. Preoperative immunomodulation of renal allograft recipients by concomitant immunosuppression and donor-specific transfusions.
    Anderson CB; Tyler JD; Rodey GE; Etheredge EE; Anderman CK; Flye MW; Jendrisak MD; Sicard GA
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1494-7. PubMed ID: 3547868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant immunosuppression and donor-specific transfusions prior to renal transplantation.
    Anderson CB; Jendrisak MD; Flye MW; Hanto DW; Anderman CK; Rodey GE; Sicard GA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1828-31. PubMed ID: 2652594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal allograft recipient immunomodulation by concomitant immunosuppression and donor-specific transfusions.
    Anderson CB; Jendrisak MD; Flye MW; Hanto DW; Anderman CK; Rodey GE; Sicard GA
    Transplant Proc; 1988 Dec; 20(6):1074-8. PubMed ID: 3059589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effects of donor-specific transfusions on long-term renal allograft function.
    Anderson CB; Brennan D; Keller C; Goss J; Shenoy S; Burton K; Sicard G; Flye MW
    Transplant Proc; 1995 Feb; 27(1):991-4. PubMed ID: 7879258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment of renal allograft recipients with immunosuppression and donor-specific blood.
    Anderson CB; Tyler JD; Sicard GA; Anderman CK; Rodey GE; Etheredge EE
    Transplantation; 1984 Dec; 38(6):664-8. PubMed ID: 6239414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment of renal allograft recipients with azathioprine and donor-specific blood products.
    Anderson CB; Sicard GA; Etheredge EE
    Surgery; 1982 Aug; 92(2):315-21. PubMed ID: 7048600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor antigen-specific immunosuppression in cadaveric and living-related donor kidney allograft recipients.
    Barber WH; Hudson SL; Deierhoi MH; Laskow DA; Gaston RS; Julian BA; Curtis JJ; Diethelm AG
    Clin Transpl; 1990; ():289-300. PubMed ID: 2103152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive prolongation of rat renal allograft survival following donor or nonspecific transfusions and concomitant immunosuppressant.
    Martin DC; Hewitt CW; Black KS; Dowdy SF; Quintero CS; Reyes M
    Transplantation; 1987 Jun; 43(6):790-4. PubMed ID: 3296345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological monitoring of posttransplant allograft sensitization following living related donor renal transplantation.
    Panigrahi A; Deka R; Bhowmik D; Tiwari SC; Mehra NK
    Transplant Proc; 2004 Jun; 36(5):1336-9. PubMed ID: 15251326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-mediated immunity to donor antigens in renal allograft recipients.
    Burrows WB; Pierce JC; Hashim GA; Ramey WG; Swistel AJ; Lee DH; Fitzpatrick HF
    Surgery; 1978 Jun; 83(6):741-5. PubMed ID: 347619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants.
    Cecka JM
    Clin Transpl; 1997; ():1-14. PubMed ID: 9919387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-transplant blood transfusion and renal allograft outcome: a report of the North American Pediatric Renal Transplant Cooperative Study.
    Chavers BM; Sullivan EK; Tejani A; Harmon WE
    Pediatr Transplant; 1997 Aug; 1(1):22-8. PubMed ID: 10084783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid withdrawal in kidney transplant recipients: is it a safe option?
    Sanfey H; Haussman G; Isaacs I; Ishitani M; Lobo P; McCullough C; Pruett T
    Clin Transplant; 1997 Oct; 11(5 Pt 2):500-4. PubMed ID: 9361950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Living donor transplants.
    Cecka JM
    Clin Transpl; 1995; ():363-77. PubMed ID: 8794280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The UNOS renal transplant registry.
    Cecka JM
    Clin Transpl; 2001; ():1-18. PubMed ID: 12211771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney transplantation by use of splenectomy and transfusions, cadaver haplotype matching, suppressor cell assays, and T-cell monitoring.
    Severyn W; Kyriakides G; Fuller L; Esquenazi V; Flaa C; Olson L; Goldsmith C; Miller J
    Surgery; 1981 Aug; 90(2):364-75. PubMed ID: 6454982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
    Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment.
    Nordén G; Briggs D; Cockwell P; Lipkin G; Mjörnstedt L; Mölne J; Ready A; Rydberg L; Samuelsson O; Svalander CT; Breimer ME
    Xenotransplantation; 2006 Mar; 13(2):148-53. PubMed ID: 16623810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.